Evidence map›Paper›PMID 37332946›Full record

ArticleHeliyon2023

Medicinal plants of Jordan: Scoping review.

Ala' Abu-Odeh, Leen Fino, Ghadeer Al-Absi, Dalal Alnatour, Mohanad Al-Darraji, Mayadah Shehadeh, Ghadeer Suaifan

Abstract readScoping Review
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Exploring the antimicrobial potential ofIranian journal of microbiology · 2025
    Article
  2. Review
  3. Unveiling the Neuroprotective Potential of Date Palm (Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  4. The effects ofFrontiers in veterinary science · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ala' Abu-OdehDepartment of Pharmaceutical Chemistry and Pharmacognosy, Applied Science Private University, Amman, Jordan.
Leen FinoDepartment of Clinical Chemistry and Therapeutics, Applied Science Private University, Amman, Jordan.
Ghadeer Al-AbsiDepartment of Pharmacy Practice, Alfaisal University, Riyadh, Saudi Arabia.
Dalal AlnatourDepartment of Clinical Chemistry and Therapeutics, Applied Science Private University, Amman, Jordan.
Mohanad Al-DarrajiApplied Science Private University, Amman, Jordan.
Mayadah ShehadehDepartment of Pharmaceutical Sciences, University of Jordan, Amman, Jordan.
Ghadeer SuaifanDepartment of Pharmaceutical Sciences, University of Jordan, Amman, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Jordan is rich in the flora of ethnobotanical importance. This scoping review aims to highlight the ethnopharmacological value of Jordanian medicinal plants using the Preferred Reporting Items of Systematic Reviews and Meta-Analysis (PRISMA) guidelines. A total of one hundred twenty-four articles published between 2000 and 2022 obtained from PubMed, EBSCO, and Google Scholar databases were included in this review. These plants own several classes of secondary bioactive metabolites, including alkaloids, flavonoids, phenolics, and terpenes. Jordanian plants exhibited potential therapeutic activity against various tumors, bacterial infections, elevated blood glucose levels, hyperlipidemia, platelets aggregation disorders, and gastrointestinal disorders. Phytochemicals' biological activities depend on their structures, parts used, methods of extraction, and evaluation model. In conclusion, this review highlights the need of researching Jordan's abundant naturally occurring medicinal plants and their phytochemicals as novel lead molecules in drug discovery and development. Studying active phytochemicals for disease treatment will help develop drugs for safe treatment and cure in the future.

Indexed as

AntimicrobialCancerDiabetesJordanMedical plantsPhytochemicals

Identifiers

PMID37332946
PMCPMC10276232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.